Skip to main content
PMC home page
PLOS ONE logoLink to PLOS ONE
. 2016 Jun 9;11(6):e0157211. doi: 10.1371/journal.pone.0157211

Correction: Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model

Daniel J Fullen, Nicolas Noulin, Andrew Catchpole, Hosnieh Fathi, Edward J Murray, Alex Mann, Kingsley Eze, Ganesh Balaratnam, Daryl W Borley, Anthony Gilbert, Rob Lambkin-Williams
PMCID: PMC4900605  PMID: 27280602

Fig 11, “Mean mucus weight by day in all subjects in the Human Viral Challenge Model.” is a duplicate of Fig 9, “Mean symptom score by day in symptom positive subjects in the Human Challenge Viral Model.” Please view the correct Fig 11 here.

Fig 11. Mean mucus weight by day in all subjects in the Human Viral Challenge Model.

Fig 11

Open in a new tab

Reference

  • 1.Fullen DJ, Noulin N, Catchpole A, Fathi H, Murray EJ, Mann A, et al. (2016) Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model. PLoS ONE 11(1): e0145902 doi: 10.1371/journal.pone.0145902 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES